Intercept Pharmaceuticals, Inc.

Swiss National Bank

Report date

9/30/2023

Quarter

2023 Q3

Filed

11/8/2023

Shares

77,900

Value ($000)

1,444

Weight

0.0%

2014 Q2 - 2023 Q3 (17 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2023 Q3	11/8/2023	1,444	0.0%	77,900	9/30/2023
2023 Q2	8/9/2023	841	0.0%	76,000	6/30/2023
2023 Q1	5/10/2023	1,021	0.0%	76,000	3/31/2023
2022 Q4	2/8/2023	993	0.0%	80,300	12/31/2022
2022 Q3	11/9/2022	776	0.0%	55,600	9/30/2022
2022 Q2	8/9/2022	768	0.0%	55,600	6/30/2022
2022 Q1	5/9/2022	966	0.0%	59,400	3/31/2022
2021 Q4	2/8/2022	1,008	0.0%	61,900	12/31/2021
2021 Q3	11/8/2021	919	0.0%	61,900	9/30/2021
2021 Q2	8/6/2021	1,236	0.0%	61,900	6/30/2021
2021 Q1	5/7/2021	1,378	0.0%	59,700	3/31/2021
2020 Q4	2/5/2021	1,475	0.0%	59,700	12/31/2020
2020 Q3	11/9/2020	2,475	0.0%	59,700	9/30/2020
2020 Q2	8/5/2020	2,812	0.0%	58,700	6/30/2020
2020 Q1	5/8/2020	3,198	0.0%	50,800	3/31/2020
2019 Q4	2/6/2020	6,208	0.0%	50,100	12/31/2019
2014 Q2	8/6/2014	3,478	0.0%	14,700	6/30/2014